CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
Mayo Clinic · NCT06220396
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 30+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- January 22, 2026
- Record last updated
- August 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate pulmonary capillary wedge pressure (PCWP) and other hemodynamic measurements at rest and during exercise in healthy volunteers across the age spectrum.
Being studied: Right Heart Catheterization with Hemodynamics and Limited Echocardiogram; Magnetic Resonance Imaging (MRI); Dual X-ray absorptiometry (DEXA) scan
Conditions: Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Apparently healthy volunteers are eligible to participate in this study if they are free of symptoms of exertional breathlessness or fatigue and any diagnosis of heart failure.
- Patients will also be required to have left ventricular ejection fraction (EF) ≥ 50%.
- Patients discovered to reduced EF or abnormal resting hemodynamics or other pathologic findings previously undiscovered will be considered screen failures and can be replaced by others to reach the goal enrollment.
- Informed consent were obtained.
- No history of heart failure.
- Willing and able to undergo invasive hemodynamic exercise testing, MRI, and other study assessments.
Exclusion Criteria
- Clinically significant symptoms of exertional dyspnea or fatigue in daily life in the opinion of the investigators.
- Any diagnosis of heart failure
- Symptomatic coronary artery disease (e.g., patients with chronic angina)
- Symptomatic valvular heart disease
- Pulmonary hypertension
- Cardiomyopathies
- High output heart failure
- Pericardial disease
- Clinically significant chronic lung disease in the opinion of the investigators
- Anemia (hemoglobin \<12 gm/dL in women and \<13 gm/dL in men)
- Estimated glomerular filtration rate ≤30mL/min
- Pregnant women
- Any other disorders or problems that would interfere with the ability to participate safely in the study (e.g. psychiatric disorder or substance abuse)
Recruiting US locations
Mayo Clinic in Rochester
Rochester, MN 55905
Site contact: Dr. Borlaug's Research Team · (507) 255-2200
Study contacts (from the official record)
- Brendon Urena · 507-538-8305 · Urena.brendon@mayo.edu
- Barry Borlaug, MD · Borlaug.Barry@mayo.edu
Similar studies in Minnesota
All healthy volunteers studies in Minnesota →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
- Location
- Dilworth, MN + 2 other US sites
- Eligibility basics
- Ages 25–75
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–75